Cargando…
Clinical Impact of Checkpoint Inhibitors as Novel Cancer Therapies
Immune responses are tightly regulated via signaling through numerous co-stimulatory and co-inhibitory molecules. Exploitation of these immune checkpoint pathways is one of the mechanisms by which tumors evade and/or escape the immune system. A growing understanding of the biology of immune checkpoi...
Autores principales: | Shih, Kent, Arkenau, Hendrik-Tobias, Infante, Jeffrey R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224737/ https://www.ncbi.nlm.nih.gov/pubmed/25344022 http://dx.doi.org/10.1007/s40265-014-0305-6 |
Ejemplares similares
-
Efficacy and safety of mycophenolate mofetil in treating immune‐related hepatitis induced by immune checkpoint inhibitor use: A retrospective study
por: Kadokawa, Yukio, et al.
Publicado: (2023) -
PARP Inhibitors in Reproductive System Cancers: Current Use and Developments
por: O’Sullivan Coyne, Geraldine, et al.
Publicado: (2017) -
Severe Acute Respiratory Syndrome: Pertinent Clinical Characteristics and Therapy
por: File, Thomas M., et al.
Publicado: (2012) -
Antisense Oligonucleotide Therapy: From Design to the Huntington Disease Clinic
por: Rook, Morgan E., et al.
Publicado: (2022) -
Use of Biologic Agents in Combination with Other Therapies for the Treatment of Psoriasis
por: Cather, Jennifer C., et al.
Publicado: (2014)